Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.

October 29, 2020

Protein Delivery by Peptide-Based Stealth Liposomes: A Biomolecular Insight into Enzyme Replacement Therapy

Molecular Pharmaceutics
Melissa SantiGiovanni Signore
October 21, 2020
Open Access

Mitochondrial collapse links PFKFB3-promoted glycolysis with CLN7/MFSD8 neuronal ceroid lipofuscinosis pathogenesis

BioRxiv : the Preprint Server for Biology
I. Lopez-FabuelJ. P. Bolanos
November 27, 2020

Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy

Nicola SpecchioFederico Vigevano
November 4, 2020
Open Access

Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease

International Journal of Molecular Sciences
Elena K Shematorova, George V Shpakovski
October 1, 2020
Case Report
Open Access

MRI findings in neuronal ceroid lipofuscinosis

Radiology Case Reports
Anna M CrainCory M Pfeifer
November 3, 2020
Open Access

Identification of a novel mutation in ATP13A2 associated with a complicated form of hereditary spastic paraplegia

Neurology. Genetics
Yasuko OdakeMitsuhiro Yoshita
October 8, 2020
Case Report
Open Access

Moyamoya and progressive myoclonic epilepsy secondary to CLN6 bi-allelic mutations - A previously unreported association

Epilepsy & Behavior Reports
Jamie TalbotFergus Rugg-Gunn
October 28, 2020
Open Access

Guidelines on the Diagnosis, Clinical Assessments, Treatment and Management for CLN2 Disease Patients

Sara E MoleRuth Williams
January 11, 2021

Inflammatory bowel disease in Hermansky-Pudlak syndrome: a retrospective single-centre cohort study

Journal of Internal Medicine
K J O'BrienB R Gochuico
October 20, 2020
Open Access

Recognizing differentiating clinical signs of CLN3 disease (Batten disease) at presentation

Acta Ophthalmologica
Willemijn F E KuperMaria M van Genderen
December 4, 2020
Open Access

Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2

Science Translational Medicine
Dolan SondhiRonald G Crystal
October 3, 2020
Open Access

Sex differences in gene expression with galactosylceramide treatment in Cln3Δex7/8 mice

PloS One
Joelle MakoukjiRose-Mary Boustany
January 6, 2021
Open Access

Generation of Pathogenic TPP1 Mutations in Human Stem Cells as a Model for CLN2 Disease

BioRxiv : the Preprint Server for Biology
L. MaEric M. Morrow
December 15, 2020

Ophthalmological manifestations of neuronal ceroid lipofuscinoses (NCL) : NCL as diseases of brain and retina-the role of ophthalmologists

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Yevgeniya AtiskovaSimon Dulz
December 21, 2020
Open Access

Impaired autophagy: The collateral damage of lysosomal storage disorders

Rachel MyerowitzNina Raben

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.


Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.

© 2021 Meta ULC. All rights reserved